Results 91 to 100 of about 5,375 (154)

Telemedicine and related technologies in South Korea:report of a DTI-supported overseas mission to South Korea in March 2001 [PDF]

, 2001
Briggs, Jim
core   +1 more source

Contemporary Oral Medication Use and Frequency in Patients with Transthyretin Amyloid Cardiomyopathy. [PDF]

Am J Cardiovasc Drugs
Dasgupta N, Poulsen SH, Emdin M, Ambardekar AV, Shah KB, Hennum L, Marwah R, Allison M, Shivanna P, Siddhanti S, Tamby JF, Falvey H, Grodin JL.   +12 more
europepmc   +1 more source

Two-Year Outcomes Following Delandistrogene Moxeparvovec Treatment in Ambulatory Patients with Duchenne Muscular Dystrophy: Phase 3 EMBARK Trial. [PDF]

Neurol Ther
Mendell JR, Muntoni F, McDonald CM, Mercuri EM, Ciafaloni E, Komaki H, Leon-Astudillo C, Nascimento A, Proud C, Schara-Schmidt U, Veerapandiyan A, Zaidman CM, Furgerson M, Ding K, Singh P, Potter R, Asher DR, Murphy AP, Reid C, Hooper G, Torre CO, Manfrini M, Rodino-Klapac LR.   +22 more
europepmc   +1 more source

Effect of Acoramidis on Myocardial Structure and Function in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Cardiac Magnetic Resonance (CMR) Substudy. [PDF]

Circ Heart Fail
Razvi Y, Judge DP, Martinez-Naharro A, Ioannou A, Venneri L, Patel R, Gillmore JD, Kellman P, Edwards L, Taubel J, Du J, Tamby JF, Castaño A, Siddhanti S, Katz L, Fox JC, Fontana M.   +16 more
europepmc   +1 more source

Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial. [PDF]

J Clin Oncol
Ratan R, Kasper B, Alcindor T, Schöffski P, van der Graaf WTA, Federman N, Bui NQ, D'Amato G, Riedel RF, Attia S, Chawla S, Lim A, Tumminello B, Oton AB, Chu Y, Zhou S, Gounder M.   +16 more
europepmc   +1 more source

Comparison of in-clinic assessment of 6MWT by conventional method and using wearable sensors for patients with ATTR-CM. [PDF]

Future Cardiol
Soman P, Khouri MG, Lenihan D, Reyentovich A, Sperry BW, Sowalsky K, Bai Y, Du J, Katz L, Siddhanti S, Fox JC.   +10 more
europepmc   +1 more source

Abstimmung auf medinfo

netbib, 2007
openaire   +2 more sources

Sparsentan in IgA nephropathy: a plain language summary of publication for the PROTECT study. [PDF]

Ther Adv Rare Dis
Rovin BH, Komers R, Scroggins C, Barratt J.   +3 more
europepmc   +1 more source

Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma. [PDF]

J Clin Oncol
Neelapu SS, Chavez JC, Sehgal AR, Epperla N, Ulrickson ML, Bachy E, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Oluwole OO, Yakoub-Agha I, Khanal R, Rosenblatt JD, Wulff J, Shen RR, Zhang W, Poddar S, Miao H, Nikolajeva O, Jacobson CA.   +22 more
europepmc   +1 more source

Increased duration of time without transfusion reliance with imetelstat vs placebo in the phase 3 IMerge trial. [PDF]

Blood Neoplasia
Sekeres MA, Santini V, Zeidan AM, Platzbecker U, Komrokji RS, Díez-Campelo M, Fenaux P, Savona MR, Madanat YF, Valcárcel D, Regnault A, Mazerolle F, Sun L, Wan Y, Berry T, Feller F, Navada S, Oliva EN.   +17 more
europepmc   +1 more source